GB1176195A - Pharmaceutical Preparations and a Process for the Manufacture thereof - Google Patents

Pharmaceutical Preparations and a Process for the Manufacture thereof

Info

Publication number
GB1176195A
GB1176195A GB4025767A GB4025767A GB1176195A GB 1176195 A GB1176195 A GB 1176195A GB 4025767 A GB4025767 A GB 4025767A GB 4025767 A GB4025767 A GB 4025767A GB 1176195 A GB1176195 A GB 1176195A
Authority
GB
United Kingdom
Prior art keywords
sedative
sept
weight
aluminium silicate
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4025767A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of GB1176195A publication Critical patent/GB1176195A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1,176,195. Sedative &c. compositions. F. HOFFMANN-LA ROCHE & CO., A.G. 4 Sept., 1967 [6 Sept., 1966], No. 40257/67. Heading A5B. Sedative, muscle relaxant and anti-convulsant compositions comprise the product formed by mixing the hydrochloric acid salt of 7- chloro-1-methyl-5-phenyl-2, 3-dihydro-1H-benzdiaz [1, 4] epine and an aluminium silicate, e.g. "Albagel" or a magnesium aluminium silicate, e.g. "Veegum", in the presence of water, e.g. at 70-85‹C., there being present in the reaction mixture at least 9 parts by weight of colloid for each part by weight of benzdiazepine compound. The reaction product is of particular value in the formulation of aqueous suspensions, due to its lack of unpleasant flavour and non-irritative nature.
GB4025767A 1966-09-06 1967-09-04 Pharmaceutical Preparations and a Process for the Manufacture thereof Expired GB1176195A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57714266A 1966-09-06 1966-09-06

Publications (1)

Publication Number Publication Date
GB1176195A true GB1176195A (en) 1970-01-01

Family

ID=24307445

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4025767A Expired GB1176195A (en) 1966-09-06 1967-09-04 Pharmaceutical Preparations and a Process for the Manufacture thereof

Country Status (6)

Country Link
BE (1) BE703421A (en)
DE (1) DE1617527A1 (en)
FR (1) FR7809M (en)
GB (1) GB1176195A (en)
MY (1) MY7000126A (en)
NL (1) NL6712213A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761207A2 (en) * 1995-08-14 1997-03-12 Rhone-Poulenc Rorer Gmbh Oral pharmaceutical preparations containing antacids
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761207A2 (en) * 1995-08-14 1997-03-12 Rhone-Poulenc Rorer Gmbh Oral pharmaceutical preparations containing antacids
EP0761207A3 (en) * 1995-08-14 1998-03-25 Rhone-Poulenc Rorer Gmbh Oral pharmaceutical preparations containing antacids
US5858413A (en) * 1995-08-14 1999-01-12 Rhone-Poulenc Rorer Gmbh Antacid composition, substantially free of preservatives
US6103274A (en) * 1995-08-14 2000-08-15 Rhone-Poulenc Rorer Gmbh Pharmaceutical, orally applicable composition
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2007108010A3 (en) * 2006-03-21 2008-05-22 Jubilant Organosys Ltd Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate

Also Published As

Publication number Publication date
DE1617527A1 (en) 1971-04-08
NL6712213A (en) 1968-03-07
BE703421A (en) 1968-03-04
MY7000126A (en) 1970-12-31
FR7809M (en) 1970-05-20

Similar Documents

Publication Publication Date Title
GB1405088A (en) Slow release formulation
Cressman et al. Complexation of penicillins and penicilloic acids by cupric ion
DE2963990D1 (en) Analgesic tablet and process for its preparation
GB1167993A (en) Novel Chemical Compounds, Process for Making Same and Method of Treatment
GB1176195A (en) Pharmaceutical Preparations and a Process for the Manufacture thereof
GB1426484A (en) Cis-20-deethy-eburnamonine
GB1130566A (en) Dentifrice
GB1196971A (en) Production of Fortified Sugar
EP0248863B1 (en) Pharmaceutical product containing a mixture of benzoic acid, phenol and an alkaline fluoride for topic treatment of herpes virus efflorescences
FR2441654A1 (en) PROCESS FOR THE PRODUCTION OF A PREPARATION OF DIMETHYLETHER PROVIDING ANY SAFETY FOR TRANSPORT, AS WELL AS A PROPELLANT IMPLEMENTING THIS PREPARATION AND AEROSOL BOMB ALLOWING THIS IMPLEMENTATION
GB1270752A (en) Dentifrice compositions
GB1334271A (en) Diazabicycloundecapentene derivative
GB1427862A (en) Antiperspirant product with a long-lasting effect
FR2456105A1 (en) PROCESS FOR THE PREPARATION OF TETRAHYDRO-PYRROLO (1,2-A) PYRIMIDINES SUBSTITUTED IN POSITION 3, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND NEW TETRAHYDRO-PYRROLO (1,2-A) PYRIMIDINES SUBSTITUTED IN POSITION 3
GB1161970A (en) Improvements in or relating to Compositions Containing Choline Chloride
GB1118606A (en) Compositions for the treatment of haemorrhoids
GB1465588A (en) Sodium aluminium phosphates
GB1212054A (en) d,l-NORZEALANE AND THE PREPARATION THEREOF
GB1364366A (en) Derivatives of 4-chloro-5-sulphamoyl-anthranilic acid their preparation and pahamaceutical compositions comprising them
GB1235266A (en) 5-nitrofuran derivatives
GB1477263A (en) Thiamindisulphidemono-orotate and process for its preparation
GB1160396A (en) Preparation of Dihydromyrcenol
GB1334326A (en) Skeletal muscle relaxant compositions
GB1337668A (en) Purification of commercial grade phosphoric acid
MIZUNO et al. Application of the Phenol-Sulufuric Acid Method for Fractional Determination of Polysaccharides.